DE60019157T2 - Herstellungsverfahren von arylethanolaminderivate zur behandlung von diabetes und fettleibigkeit - Google Patents

Herstellungsverfahren von arylethanolaminderivate zur behandlung von diabetes und fettleibigkeit Download PDF

Info

Publication number
DE60019157T2
DE60019157T2 DE60019157T DE60019157T DE60019157T2 DE 60019157 T2 DE60019157 T2 DE 60019157T2 DE 60019157 T DE60019157 T DE 60019157T DE 60019157 T DE60019157 T DE 60019157T DE 60019157 T2 DE60019157 T2 DE 60019157T2
Authority
DE
Germany
Prior art keywords
alkyl
radical
compound
formula
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60019157T
Other languages
German (de)
English (en)
Other versions
DE60019157D1 (de
Inventor
Maxwell Ronnie Stevenage LAWRENCE
Alan Millar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE60019157D1 publication Critical patent/DE60019157D1/de
Application granted granted Critical
Publication of DE60019157T2 publication Critical patent/DE60019157T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
DE60019157T 1999-12-11 2000-12-08 Herstellungsverfahren von arylethanolaminderivate zur behandlung von diabetes und fettleibigkeit Expired - Lifetime DE60019157T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9929297 1999-12-11
GBGB9929297.1A GB9929297D0 (en) 1999-12-11 1999-12-11 Process
PCT/GB2000/004697 WO2001042195A1 (en) 1999-12-11 2000-12-08 Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties

Publications (2)

Publication Number Publication Date
DE60019157D1 DE60019157D1 (de) 2005-05-04
DE60019157T2 true DE60019157T2 (de) 2006-02-02

Family

ID=10866125

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60019157T Expired - Lifetime DE60019157T2 (de) 1999-12-11 2000-12-08 Herstellungsverfahren von arylethanolaminderivate zur behandlung von diabetes und fettleibigkeit

Country Status (23)

Country Link
US (1) US6548523B2 (cg-RX-API-DMAC10.html)
EP (1) EP1235788B1 (cg-RX-API-DMAC10.html)
JP (1) JP4903964B2 (cg-RX-API-DMAC10.html)
KR (1) KR100683614B1 (cg-RX-API-DMAC10.html)
CN (1) CN1224609C (cg-RX-API-DMAC10.html)
AT (1) ATE292110T1 (cg-RX-API-DMAC10.html)
AU (1) AU769387B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0016187B1 (cg-RX-API-DMAC10.html)
CA (1) CA2394117C (cg-RX-API-DMAC10.html)
CZ (1) CZ303143B6 (cg-RX-API-DMAC10.html)
DE (1) DE60019157T2 (cg-RX-API-DMAC10.html)
ES (1) ES2236020T3 (cg-RX-API-DMAC10.html)
GB (1) GB9929297D0 (cg-RX-API-DMAC10.html)
HK (1) HK1045988B (cg-RX-API-DMAC10.html)
HU (1) HU229043B1 (cg-RX-API-DMAC10.html)
IL (1) IL149585A0 (cg-RX-API-DMAC10.html)
NO (1) NO323239B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ518795A (cg-RX-API-DMAC10.html)
PL (1) PL200540B1 (cg-RX-API-DMAC10.html)
PT (1) PT1235788E (cg-RX-API-DMAC10.html)
TR (1) TR200201528T2 (cg-RX-API-DMAC10.html)
WO (1) WO2001042195A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200204585B (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10230147A1 (de) * 2001-10-09 2004-01-15 Profos Ag Verfahren zur unspezifischen Anreicherung von Bakterienzellen
US7158049B2 (en) * 2003-03-24 2007-01-02 Schlumberger Technology Corporation Wireless communication circuit
US8213085B2 (en) * 2008-01-18 2012-07-03 Visera Technologies Company Limited Image sensor device with high photosensitivity
US8778998B2 (en) 2009-04-10 2014-07-15 Auspex Pharmaceuticals, Inc. Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
US9907767B2 (en) 2010-08-03 2018-03-06 Velicept Therapeutics, Inc. Pharmaceutical compositions and the treatment of overactive bladder
PE20131341A1 (es) 2010-08-03 2013-12-07 Altherx Inc Combinaciones de agonistas del receptor beta-3-adrenergico y antagonistas del receptor muscarinico para tratar vejiga hiperactiva
TW201338772A (zh) 2012-02-09 2013-10-01 Altherx Inc 藥學組合物
MX2017007054A (es) 2014-12-03 2018-05-02 Velicept Therapeutics Inc Composiciones y métodos para usar solabegron de liberación modificada para sintomas del tracto urinario inferior.
CN108290824B (zh) 2015-10-23 2022-03-11 B3Ar治疗股份有限公司 索拉贝隆两性离子及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1551260A (en) 1976-02-09 1979-08-30 Allen & Hanburys Ltd Phenylethanolamine derivatives
JP2577222B2 (ja) * 1987-04-10 1997-01-29 興和株式会社 新規な置換アニリド誘導体
NO179246C (no) * 1991-11-20 1996-09-04 Sankyo Co Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav
GB9525121D0 (en) * 1995-12-08 1996-02-07 Glaxo Group Ltd Chemical compounds
SK16282000A3 (sk) * 1998-05-01 2001-05-10 Abbott Laboratories Substituované beta-aminokyselinové inhibítory metionínaminopeptidázy-2
GB9812709D0 (en) * 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
ES2236020T3 (es) 2005-07-16
NO20022758L (no) 2002-07-01
EP1235788A1 (en) 2002-09-04
KR20020061636A (ko) 2002-07-24
GB9929297D0 (en) 2000-02-02
WO2001042195A1 (en) 2001-06-14
HK1045988A1 (en) 2002-12-20
US6548523B2 (en) 2003-04-15
NZ518795A (en) 2004-02-27
CN1409700A (zh) 2003-04-09
HUP0203640A3 (en) 2003-08-28
JP4903964B2 (ja) 2012-03-28
PL200540B1 (pl) 2009-01-30
NO323239B1 (no) 2007-02-05
CZ303143B6 (cs) 2012-05-02
DE60019157D1 (de) 2005-05-04
KR100683614B1 (ko) 2007-02-16
AU769387B2 (en) 2004-01-22
PL356483A1 (en) 2004-06-28
PT1235788E (pt) 2005-08-31
CN1224609C (zh) 2005-10-26
IL149585A0 (en) 2002-11-10
HK1045988B (en) 2005-07-15
TR200201528T2 (tr) 2002-09-23
CA2394117C (en) 2011-10-04
HUP0203640A2 (hu) 2003-02-28
ZA200204585B (en) 2003-12-31
AU2191101A (en) 2001-06-18
EP1235788B1 (en) 2005-03-30
CA2394117A1 (en) 2001-06-14
ATE292110T1 (de) 2005-04-15
HU229043B1 (hu) 2013-07-29
JP2003516383A (ja) 2003-05-13
CZ20022017A3 (cs) 2003-01-15
NO20022758D0 (no) 2002-06-10
US20020198220A1 (en) 2002-12-26
BR0016187A (pt) 2002-08-13
BRPI0016187B1 (pt) 2016-08-02

Similar Documents

Publication Publication Date Title
DE60133584T2 (de) 4-arylpiperidine als opioidrezeptorbindende agenzien
CN102317263A (zh) 用作杀虫剂的卤素取代化合物
DE60309057T2 (de) Azabicycloderivate als antagonisten des muscarinischen rezeptors
BRPI0707185A2 (pt) imidazóis substituìdos e sua utilização como pesticidas
DE3617183A1 (de) Substituierte benzylether
DE69408580T2 (de) 2-amino-1,2,3,4-tetrahydronaphthalenderivate mit cardiovaskulärer wirkung
CN103108866B (zh) 环己烷衍生物化合物
DD283603A5 (de) Verfahren zur herstellung von substituierten hydroxylaminen
EP1235788B1 (en) Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties
EP0229011A1 (de) Trisubstituierte Triazole
EP0389425B1 (de) Neue Benzothiopyranylamine
KR20100117142A (ko) Hdl-콜레스테롤 상승제로서 2-트라이플루오로메틸니코틴아미드 유도체
DE102011118606A1 (de) Stilben-Verbindungen als PPAR beta/delta Inhibitoren für die Behandlung von PPAR beta/delta-vermittelten Erkrankungen
WO2006115895A2 (en) Phenyl ethyne compounds
DE3829431A1 (de) Sulfonamide mit tetrazolylrest, verfahren zur ihrer herstellung sowie arzneimittel
JP2019511459A (ja) ジピロリジンペプチド化合物の合成プロセス
CN1865234A (zh) 辣椒碱的化学合成与纯化方法
CN116162039B (zh) 一种可见光介导的丁二酰胺类化合物的合成方法
Cież et al. Synthesis of optically active isothiazole derivatives from L-(α)-amino acids
DE19612828C1 (de) Verfahren zur Herstellung von Naphthonitrilderivaten und deren Verwendung zur Herstellung von Faktor-Xa-Inhibitoren
DE69705316T2 (de) Phenoxyethylaminderivate, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und deren pharmazeutische zusammensetzungen
AT412720B (de) Verfahren zur herstellung von chiralen alpha-aminoalkoholen durch reduktion von chiralen cyanhydrinen
DE2345651A1 (de) Indolylalkylamine und verfahren zu ihrer herstellung
DE2341430A1 (de) Neue alpha-phenylfettsaeureverbindungen
DE3726632A1 (de) 1,2-diamino-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition